Predicting the Role of DNA Polymerase β Alone or with KRAS Mutations in Advanced NSCLC Patients Receiving Platinum-Based Chemotherapy
预测 DNA 聚合酶 β 单独或与 KRAS 突变一起对接受铂类化疗的晚期 NSCLC 患者的作用
期刊:Journal of Clinical Medicine
影响因子:3
doi:10.3390/jcm9082438
Maria Francesca Alvisi, Monica Ganzinelli, Helena Linardou, Elisa Caiola, Giuseppe Lo Russo, Fabiana Letizia Cecere, Anna Cecilia Bettini, Amanda Psyrri, Michele Milella, Eliana Rulli, Alessandra Fabbri, Marcella De Maglie, Pierpaolo Romanelli, Samuel Murray, Gloriana Ndembe, Massimo Broggini, Marin
